Drug delivery, cancer therapy, and immunisation are all becoming increasingly personalised because to nanotechnology. There is a huge demand for an effective nanocarrier delivery system with low toxicity and high capacity for modularization, as customised and precision medicine is now one of the key emphasis points of nanotechnology and nanopharmacological studies. Numerous nanocarrier systems made of both natural and synthetic materials have been presented; yet, it is still difficult to get beyond biological obstacles, toxicity, target precision, and encapsulation efficiency. Here, we provide a summary of the most recent developments in BioCapZ, a protein-capsid-based nanocarrier that serves as a nano-platform for the non-invasive administration of vaccinations, gene-editing tools, imaging agents, and theranostics.
Author(s) Details:
Mo. A. Baikoghli,
Department of Molecular and Cellular Biology, University of California, Davis, CA, USA and Institute for Molecular Medicine, (FIMM), Hi Life, University of Helsinki, Finland.
Chun-Chieh Chen,
Astrid Pharma Corp., Davis, CA, USA.
R. Holland Cheng,
Department of Molecular and Cellular Biology, University of California, Davis, CA, USA.
Please see the link here: https://stm.bookpi.org/CPMS-V4/article/view/7368
No comments:
Post a Comment